Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Sympathectomy-induced blood pressure reduction in adult normotensive and hypertensive rats is counteracted by enhanced cardiovascular sensitivity to vasoconstrictors

A. Vavřínová, M. Behuliak, M. Bencze, M. Vodička, P. Ergang, I. Vaněčková, J. Zicha,

. 2019 ; 42 (12) : 1872-1882. [pub] 20190917

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV15-25396A MZ0 CEP Register

Digital library NLK
Full text - Article

E-resources Online Full text

NLK ProQuest Central from 2015-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2015-01-01 to 1 year ago

The effect of chemical sympathectomy on cardiovascular parameters and the compensatory role of adrenal hormones, the renin-angiotensin system, and cardiovascular sensitivity to vasoconstrictors were studied in spontaneously hypertensive rats (SHRs) and normotensive Wistar-Kyoto (WKY) rats. Sympathectomy was induced in 20-week-old rats by daily intraperitoneal guanethidine administration (30 mg/kg b.w.) for 2 weeks. Basal blood pressure (BP), heart rate (HR), and restraint stress-induced cardiovascular changes were measured by radiotelemetry. The BP response to catecholamines was determined in rats with implanted catheters. Sympathectomy decreased BP only transiently, and after 14-day guanethidine treatment, BP returned to basal values in both strains. Sympathectomy permanently lowered HR, improved baroreflex sensitivity, and decreased the low-frequency domain of systolic blood pressure variability (a marker of vascular sympathetic activity). Guanethidine also attenuated the BP and HR responses to restraint stress. On the other hand, the BP response to catecholamines was augmented in sympathectomized rats, and this was not due to the de novo synthesis of vascular adrenergic receptors. Sympathectomy caused adrenal enlargement, enhanced the expression of adrenal catecholamine biosynthetic enzymes, and elevated plasma adrenaline levels in both strains, especially in WKY rats. Guanethidine also increased the plasma levels of aldosterone and corticosterone in WKY rats only. In conclusion, sympathectomy produced a transient decrease in BP, a chronic decrease in HR and improvement in baroreflex sensitivity. The effect of sympathectomy on BP was counteracted by increased vascular sensitivity to catecholamines in WKY rats and SHRs and/or by the enhanced secretion of adrenal hormones, which was more pronounced in WKY rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028735
003      
CZ-PrNML
005      
20250618084852.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41440-019-0319-2 $2 doi
035    __
$a (PubMed)31527789
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vavřínová, Anna, $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. anna.vavrinova@fgu.cas.cz. Faculty of Science, Charles University, Prague, Czech Republic. anna.vavrinova@fgu.cas.cz. $d 1989- $7 xx0261137
245    10
$a Sympathectomy-induced blood pressure reduction in adult normotensive and hypertensive rats is counteracted by enhanced cardiovascular sensitivity to vasoconstrictors / $c A. Vavřínová, M. Behuliak, M. Bencze, M. Vodička, P. Ergang, I. Vaněčková, J. Zicha,
520    9_
$a The effect of chemical sympathectomy on cardiovascular parameters and the compensatory role of adrenal hormones, the renin-angiotensin system, and cardiovascular sensitivity to vasoconstrictors were studied in spontaneously hypertensive rats (SHRs) and normotensive Wistar-Kyoto (WKY) rats. Sympathectomy was induced in 20-week-old rats by daily intraperitoneal guanethidine administration (30 mg/kg b.w.) for 2 weeks. Basal blood pressure (BP), heart rate (HR), and restraint stress-induced cardiovascular changes were measured by radiotelemetry. The BP response to catecholamines was determined in rats with implanted catheters. Sympathectomy decreased BP only transiently, and after 14-day guanethidine treatment, BP returned to basal values in both strains. Sympathectomy permanently lowered HR, improved baroreflex sensitivity, and decreased the low-frequency domain of systolic blood pressure variability (a marker of vascular sympathetic activity). Guanethidine also attenuated the BP and HR responses to restraint stress. On the other hand, the BP response to catecholamines was augmented in sympathectomized rats, and this was not due to the de novo synthesis of vascular adrenergic receptors. Sympathectomy caused adrenal enlargement, enhanced the expression of adrenal catecholamine biosynthetic enzymes, and elevated plasma adrenaline levels in both strains, especially in WKY rats. Guanethidine also increased the plasma levels of aldosterone and corticosterone in WKY rats only. In conclusion, sympathectomy produced a transient decrease in BP, a chronic decrease in HR and improvement in baroreflex sensitivity. The effect of sympathectomy on BP was counteracted by increased vascular sensitivity to catecholamines in WKY rats and SHRs and/or by the enhanced secretion of adrenal hormones, which was more pronounced in WKY rats.
650    _2
$a nadledviny $x růst a vývoj $x metabolismus $x patofyziologie $7 D000311
650    _2
$a zvířata $7 D000818
650    _2
$a baroreflex $x účinky léků $7 D017704
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a cévy $x účinky léků $x inervace $x patofyziologie $7 D001808
650    _2
$a kardiovaskulární fyziologické jevy $x účinky léků $7 D002320
650    _2
$a katecholaminy $x metabolismus $7 D002395
650    _2
$a guanethidin $x farmakologie $7 D006145
650    _2
$a srdeční frekvence $x účinky léků $7 D006339
650    _2
$a hypertenze $x patofyziologie $7 D006973
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a potkani inbrední WKY $7 D011921
650    _2
$a fyzické omezení $7 D012149
650    _2
$a psychický stres $7 D013315
650    _2
$a sympatolytika $x farmakologie $7 D013565
650    _2
$a vazokonstriktory $x farmakologie $7 D014662
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. $7 xx0196023
700    1_
$a Bencze, Michal, $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. $d 1986- $7 av2016924515
700    1_
$a Vodička, Martin $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Ergang, Peter $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
773    0_
$w MED00006041 $t Hypertension research $x 1348-4214 $g Roč. 42, č. 12 (2019), s. 1872-1882
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31527789 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20250618084843 $b ABA008
999    __
$a ok $b bmc $g 1609070 $s 1119915
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 42 $c 12 $d 1872-1882 $e 20190917 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
GRA    __
$a NV15-25396A $p MZ0
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...